4-茚醇 | 1641-41-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 中文名称: 4-茚醇
• 英文名称: 4-indanol
• 英文别名: 2,3-dihydro-1H-inden-4-ol；indan-4-ol；4-hydroxyindane；Indanol-(4)
• CAS: 1641-41-4
• 化学式: C₉H₁₀O
• mdl: MFCD00053431
• 分子量: 134.178
• InChiKey: DPHNJPUOMLRELT-UHFFFAOYSA-N

物化性质

• 熔点：
  47-51 °C
• 沸点：
  245 °C
• 密度：
  1.147±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  6.1
• 海关编码：
  2907199090
• 危险性防范说明：
  P305+P351+P338
• 危险性描述：
  H302,H315,H319
• 储存条件：
  室温且干燥

SDS

Name:	4-Indanol 98% Material Safety Data Sheet
Synonym:
CAS:	1641-41-4

Section 1 - Chemical Product MSDS Name:4-Indanol 98% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1641-41-4	4-INDANOL, 98%		216-691-9

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Flammable liquid and vapor.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal.

---

Section 7 - HANDLING and STORAGE
Handling:
Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep away from heat, sparks and flame.
Storage:
Keep away from heat, sparks, and flame.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 1641-41-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure. Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Not available.
Color: Slightly brownish crystalline powder
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H10O
Molecular Weight: 134.18

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1641-41-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-INDANOL, 98% - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1641-41-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1641-41-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1641-41-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-茚醇 在 potassium dihydrogenphosphate 、 potassium nitrososulfonate 作用下， 以 甲醇 为溶剂， 反应 15.0h， 生成
  参考文献：
  名称：

  Synthesis and characterization of a 14-membered polyketide lactone

  摘要：

  A stable 14-membered polyketide lactone having a C-methyl group at C- 1 3 has been synthesized and elucidated to have the bis-enol structure by X-ray crystallographic analysis, and its hydride reduction to the tetraols has also been described.

  DOI：

  10.1016/s0040-4039(00)74056-1
• 作为产物：
  描述：

  茚满 在 三氯化铝 、 甲酸 、 双氧水 作用下， 以 甲苯 为溶剂， 反应 2.0h， 生成 4-茚醇
  参考文献：
  名称：

  Dallacker,F.; Van Werst,J., Chemische Berichte, 1972, vol. 105, p. 2565 - 2574

  摘要：

  DOI：

文献信息

• Ruthenium-Catalyzed Aromatization of Enediynes via Highly Regioselective Nucleophilic Additions on a π-Alkyne Functionality. A Useful Method for the Synthesis of Functionalized Benzene Derivatives
  作者：Arjan Odedra、Chang-Jung Wu、Taduri Bhanu Pratap、Chun-Wei Huang、Ying-Fen Ran、Rai-Shung Liu

  DOI：10.1021/ja043047j

  日期：2005.3.1

  TpRu(PPh3)(CH3CN)2 PF6 (10 mol %) catalyst effected the nucleophilic addition of water, alcohols, aniline, acetylacetone, pyrroles, and dimethyl malonate to unfunctionalized enediynes under suitable conditions (100 degrees C, 12-24 h) and gave functionalized benzene products in good yields. In this novel cyclization, nucleophiles very regioselectively attack the internal C1' alkyne carbon of enediynes

  TpRu(PPh3)(CH3CN)2 PF6 (10 mol %) 催化剂在合适的条件下（100 摄氏度，12-24 小时）实现了水、醇、苯胺、乙酰丙酮、吡咯和丙二酸二甲酯与未官能化的烯二炔的亲核加成和以良好的收率得到官能化苯产物。在这种新颖的环化中，亲核试剂非常区域选择性地攻击烯二炔的内部 C1' 炔烃碳，得到苯衍生物作为单一区域异构体。使用甲氧基取代基的实验排除了萘基阳离子作为反应中间体参与（邻乙炔基苯基）炔烃环化的可能。氘标记实验表明催化活性物质是钌-π-炔烃而不是钌-亚乙烯基物质。o-(2' -碘乙炔基）苯基炔烃与醇。我们在一系列实验的基础上提出了这种亲核芳构化的亲核加成/插入机制。
• Structure−Activity Relationships of Potent, Selective Inhibitors of Neuronal Nitric Oxide Synthase Based on the 6-Phenyl-2-aminopyridine Structure
  作者：John A. Lowe、Weimin Qian、Susan E. Drozda、Robert A. Volkmann、Deane Nason、Robert B. Nelson、Charles Nolan、Dane Liston、Karen Ward、Steve Faraci、Kim Verdries、Pat Seymour、Michael Majchrzak、Anabella Villalobos、W. Frost White

  DOI：10.1021/jm030519g

  日期：2004.3.1

  The synthesis and structure-activity relationships of a series of 6-phenyl-2-aminopyridines that potently and selectively inhibit the neuronal isoform of nitric oxide synthase (nNOS) are described. Compound 14bi from this series exhibits potent in vivo activity in harmaline-induced cGMP formation in rat cerebellum, a functional model of nNOS inhibition, and in the PCP-induced hypermotility model in

  描述了一系列6-苯基-2-氨基吡啶的合成和结构-活性关系，这些6-苯基-2-氨基吡啶有效和选择性地抑制一氧化氮合酶（nNOS）的神经元亚型。来自该系列的化合物14bi在大鼠小脑中由harmaline诱导的cGMP形成，nNOS抑制的功能模型以及在PCP诱导的高运动性模型中表现出强大的体内活性。这些结果表明，14bi可能是用于评估nNOS抑制剂在中枢神经系统中潜在治疗应用的有用试剂。
• Thienopyridone derivatives useful as activators of AMPK
  申请人：Poxel

  公开号：EP2679591A1

  公开（公告）日：2014-01-01

  The invention relates to compounds that are direct activators of AMPK (AMP-activated protein kinase) and their use in the treatment of disorders regulated by activation of AMPK. For instance, compounds according to the invention are useful for the treatment of diabetes, metabolic syndrome, obesity, liver disease, hepatic steatosis, non alcoholic fatty liver disease (NAFLD), non alcoholic steato-hepatitis (NASH), liver fibrosis, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, inflammation, cancer, cardiovascular diseases, atherosclerosis, high blood pressure, retinopathies or neuropathies.

  该发明涉及直接激活AMPK（AMP-激活蛋白激酶）的化合物及其在治疗受AMPK激活调节的疾病中的应用。例如，根据该发明的化合物对于治疗糖尿病、代谢综合征、肥胖、肝病、肝脂肪变性、非酒精性脂肪肝病（NAFLD）、非酒精性脂肪肝炎（NASH）、肝纤维化、血脂异常、高三酰甘油血症、高胆固醇血症、炎症、癌症、心血管疾病、动脉粥样硬化、高血压、视网膜病变或神经病变方面具有用处。
• 含苯并脂肪环结构的氨基乙酰胺类化合物及其用途
  申请人：华东理工大学

  公开号：CN108997163A

  公开（公告）日：2018-12-14

  本发明涉及一种含苯并脂肪环结构的氨基乙酰胺类化合物及其用途。所述的氨基乙酰胺类化合物所述的氨基乙酰胺类化合物，为式I所示化合物，或其旋光异构体或在药学上可接受的盐：式I中，R1为氢，C1～C6的直链或支链烷基或苯基；R2为C1～C7的直链或支链烷基，5～6元的芳环基、杂芳环基或环烷基，或取代的5～6元的芳环基、芳杂环基或环烷基；A为亚烷基或羰基；n为1～3的整数；其中，所述取代的5～6元的芳环基、杂芳环基或环烷基的取代基选自下列基团中一种或两种以上：卤素，C1～C3的烷基或烷氧基，C1～C3的含氟烷基或含氟烷氧基，硝基或氰基；所述的芳杂环基的杂原子为氮或硫；m为1～3的整数。本发明提供的氨基乙酰胺类化合物可用作抗癫痫药物或离子通道阻滞剂。
• [EN] MACROCYCLIC INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS D'INDOLE MACROCYCLIQUES
  申请人：BROAD INST INC

  公开号：WO2019096911A1

  公开（公告）日：2019-05-23

  The present invention relates to macrocyclic indole derivatives of general formula (I), in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

  本发明涉及通式（I）所示的大环吲哚衍生物，其中R1、R2、R3、R4、R5、R6、A和L如本文所定义，制备所述化合物的方法，用于制备所述化合物的有用中间体化合物，包含所述化合物的药物组合物和组合物，以及利用所述化合物制造用于治疗或预防疾病的药物组合物，特别是治疗过度增殖性疾病的唯一药物或与其他活性成分组合使用。